![Inactivation of p53 in Human Keratinocytes Leads to Squamous Differentiation and Shedding via Replication Stress and Mitotic Slippage - ScienceDirect Inactivation of p53 in Human Keratinocytes Leads to Squamous Differentiation and Shedding via Replication Stress and Mitotic Slippage - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124714008663-fx1.jpg)
Inactivation of p53 in Human Keratinocytes Leads to Squamous Differentiation and Shedding via Replication Stress and Mitotic Slippage - ScienceDirect
![Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53 | Journal of Ovarian Research | Full Text Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53 | Journal of Ovarian Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13048-019-0516-2/MediaObjects/13048_2019_516_Fig1_HTML.png)
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53 | Journal of Ovarian Research | Full Text
![PDF] Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors | Semantic Scholar PDF] Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b917d5b91b38642cf5a46bc1cb8cdea1921e2c4a/4-Figure1-1.png)
PDF] Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors | Semantic Scholar
![IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors](https://www.mdpi.com/ijms/ijms-20-05999/article_deploy/html/images/ijms-20-05999-g002-550.jpg)
IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
![Model for the dominant-negative mechanism of TA-p73. A, inhibition of... | Download Scientific Diagram Model for the dominant-negative mechanism of TA-p73. A, inhibition of... | Download Scientific Diagram](https://www.researchgate.net/publication/11516060/figure/fig7/AS:338402797998080@1457692922050/Model-for-the-dominant-negative-mechanism-of-TA-p73-A-inhibition-of-p53-by-direct.png)
Model for the dominant-negative mechanism of TA-p73. A, inhibition of... | Download Scientific Diagram
![Dominant-negative effect of mutant p53 on wild-type p53. Pro-apoptotic... | Download Scientific Diagram Dominant-negative effect of mutant p53 on wild-type p53. Pro-apoptotic... | Download Scientific Diagram](https://www.researchgate.net/publication/258429534/figure/fig1/AS:203169742233604@1425450849177/Dominant-negative-effect-of-mutant-p53-on-wild-type-p53-Pro-apoptotic-function-of-p53-is.png)
Dominant-negative effect of mutant p53 on wild-type p53. Pro-apoptotic... | Download Scientific Diagram
![Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation: Molecular Cell Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation: Molecular Cell](https://www.cell.com/cms/attachment/30c8ff00-8bd2-44a7-b2e0-0120e2197322/fx1_lrg.jpg)
Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation: Molecular Cell
![Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model | Gene Therapy Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fgt.2014.70/MediaObjects/41434_2014_Article_BFgt201470_Fig1_HTML.jpg)
Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model | Gene Therapy
![ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions - ScienceDirect ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253121001906-fx1.jpg)
ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions - ScienceDirect
![The role of mutant p53 in human cancer - Goh - 2011 - The Journal of Pathology - Wiley Online Library The role of mutant p53 in human cancer - Goh - 2011 - The Journal of Pathology - Wiley Online Library](https://pathsocjournals.onlinelibrary.wiley.com/cms/asset/75c7e643-b1dd-49d7-9cf1-3e7b85183adc/mfig001.jpg)
The role of mutant p53 in human cancer - Goh - 2011 - The Journal of Pathology - Wiley Online Library
![Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes | Oncogene Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes | Oncogene](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.onc.1207396/MediaObjects/41388_2004_Article_BF1207396_Fig2_HTML.jpg)